Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
11/2013
11/06/2013CN101757057B Whiteflower leadword root chewable tablet
11/06/2013CN101732306B New application of natural product amentoflavone in treating cancers
11/06/2013CN101721513B Pharmaceutical composition for preventing and treating cancer and health food containing the same for preventing and treating cancer
11/06/2013CN101678213B Cyclic peptide cxcr4 antagonists
11/06/2013CN101633609B New compound separated from leaves of rubus corchorifolius and preparation method and use thereof
11/06/2013CN101632833B Prostatic cancer related gene and application thereof
11/06/2013CN101628111B Taci-immunoglobulin fusion proteins
11/06/2013CN101611005B Substituted acetophenones useful as PDE4 inhibitors
11/06/2013CN101534904B BCL inhibitors treating platelet excess
11/06/2013CN101484471B Anti-NKG2A antibodies and uses thereof
11/06/2013CN101484391B Method for activating and stabilizing dissolved hydrogen in water
11/06/2013CN101475506B Antineoplastic use of higher fatty acid derivative novel compound
11/06/2013CN101466736B Therapy targeting cathepsin S
11/06/2013CN101454341B Use of multivalent synthetic ligands of surface nucleolin for treating cancer or inflammation
11/06/2013CN101365703B Heteroalkyl linked pyrimidine derivatives
11/06/2013CN101302515B Human antibodies that bind human TNF(alpha)
11/06/2013CN101287724B Solid salt forms of a pyrrole substituted 2-indolinone
11/06/2013CN101073667B Enhancer for antibody to lymphocytic tumors
11/06/2013CN101010302B Sigma receptor inhibitors
11/05/2013US8575340 Purine derivatives and their pharmaceutical uses
11/05/2013US8575204 Nicotinamide derivates useful as P38 inhibitors
11/05/2013US8575180 9-substituted 8-oxoadenine compound
11/05/2013US8575147 Spontaneously dispersible N-benzoyl staurosporine compositions
11/05/2013US8575145 Triazolopyridine compounds as PIM kinase inhibitors
11/05/2013US8575138 Method for providing neuroprotection
11/05/2013US8574599 Methods and products for inducing mucosal immunity
11/05/2013US8574586 KDR peptides and vaccines comprising the same
11/05/2013US8574585 KDR peptides and vaccines comprising the same
11/05/2013CA2690395C Use of bi-specific antibodies for pre-targeting diagnosis and therapy
11/05/2013CA2656064C Polymorphic forms and process
11/05/2013CA2594345C Compositions and methods of treating cell proliferation disorders
11/05/2013CA2514485C Compositions comprising fetal hemoglobin and bacterial endotoxin and optionally additional fetal liver components
11/05/2013CA2512673C 2-o sulfatase compositions and related methods
11/05/2013CA2491994C Modulators of the glucocorticoid receptor
11/05/2013CA2394015C Tweak receptor
11/05/2013CA2341037C Bioactive peptides
10/2013
10/31/2013WO2013163519A1 Anti-cd22 antibodies
10/31/2013WO2013163258A1 Microrna compounds and methods for modulating mir-21 activity
10/31/2013WO2013163239A1 Synthesis of lactams
10/31/2013WO2013162922A1 Taxane compounds, compositions and methods
10/31/2013WO2013162760A1 Novel cyclotides with anticancer activity
10/31/2013WO2013162714A1 Highly pure pyrroloquinolinyl-pyrrole-2,5-dione and pyrroloquinolinyl-pyrrolidine-2,5-dione and methods of preparing same
10/31/2013WO2013162484A1 A combination of fig (ficus carica) fruit extract and olive (olea europaea) leaf extract
10/31/2013WO2013162469A1 Tubulin inhibitors
10/31/2013WO2013162061A1 Bicyclic pyrimidine compound
10/31/2013WO2013162054A1 Composition for controlling chromatin structure
10/31/2013WO2013162050A1 Lactoferrin fusion protein and method for producing same
10/31/2013WO2013162021A1 Prophylactic or therapeutic agent for hepatic diseases
10/31/2013WO2013162016A1 New carbamate glycolipid and use thereof
10/31/2013WO2013161853A1 Quinazolinedione derivative
10/31/2013WO2013161851A1 Benzamide derivative
10/31/2013WO2013161848A1 Novel 1,2,4-triazine derivative
10/31/2013WO2013161408A1 Method for inducing t cell differentiation, method for producing t cells, t cells, pharmaceutical composition, and screening method
10/31/2013WO2013161378A1 Method for producing composition containing fucoxanthin
10/31/2013WO2013160645A1 Dexanabinol or a derivative thereof for use in the treatment of cancer in dose ranges of 2-30 mg/kg
10/31/2013WO2013160498A1 Human anti-her2 monoclonal antibody
10/31/2013WO2013160396A1 Combination of cd37 antibodies with bendamustine
10/31/2013WO2013160359A1 Anti-pdgf-c antibodies
10/31/2013WO2013159698A1 Fused ring quinazoline hydroximic acid compound and use thereof as anti-tumour drug
10/31/2013WO2013159422A1 Small molecular peptide and use thereof
10/31/2013WO2013159419A1 Use of seminal plasma
10/31/2013WO2013159224A1 2-carbamo(thio)yl-1,3- dioxopropyl derivatives in cancer therapy
10/31/2013WO2013159200A1 Assays, methods and apparatus for assessing rna disruption
10/31/2013WO2013159155A1 Oncolytic clostridium ghonii strains, and methods of production and use
10/31/2013WO2013159140A1 Eds005 skin cancer cream
10/31/2013WO2013130672A3 Improved cancer treatments and diagnostics
10/31/2013WO2013124701A3 Homo- and heterodimeric smac mimetic compounds as apoptosis inducers
10/31/2013WO2013115926A3 Aspartyl-trna synthetase-fc conjugates
10/31/2013WO2013055899A3 Compositions useful in treating nephropathy and methods for preparation of same
10/31/2013WO2004061073A9 Novel human proteins, polynucleotides encoding them and methods of using the same
10/31/2013WO2003023014A9 Human ion channels
10/31/2013WO2002078598A3 Peptides and antibodies to muc 1 proteins
10/31/2013WO2002069885A9 Anti-invasive and anti-angiogenic compositions and methods for treating brain tumors and other diseases
10/31/2013US20130289026 Isoxazole Compounds As Inhibitors Of Heat Shock Proteins
10/31/2013US20130287769 Treatment of solid tumors with rapamycin derivatives
10/30/2013EP2657353A1 Ultraconserved regions encoding ncRNAs
10/30/2013EP2657339A2 Gene delivery system having enhanced tumor-specific expression, and recombinant gene expression regulating sequence
10/30/2013EP2657253A2 Anti-CD79b antibodies and immunoconjugates and methods of use
10/30/2013EP2657252A2 Modified human tumor necrosis factor receptor-1 polypeptide or fragment thereof and method for preparing same
10/30/2013EP2657245A1 Fructosylated mangiferin and preparation method therefor and use thereof
10/30/2013EP2657242A2 Amphiphilic cyclic phosphazene trimer, hydrophobic pharmaceutical formulation micellized by amphiphilic cyclic phosphazene trimer, and preparation methods thereof
10/30/2013EP2657241A1 Diphenyl sulfide derivative and pharmaceutical product which contains same as active ingredient
10/30/2013EP2657238A1 Macrolide compound having anticancer effect
10/30/2013EP2657235A1 Compound containing basic group and use thereof
10/30/2013EP2657233A1 3,5-disubstituted alkynylbenzene compound and salt thereof
10/30/2013EP2657223A1 Metal-salen complex compound and production method for same
10/30/2013EP2656851A1 Semuloparin for improving the survival of patients with cancer
10/30/2013EP2656849A1 Liposome comprising combination of chloroquine and adriamycin and preparation method thereof
10/30/2013EP2656844A1 Antineoplastic combinations containing HKI-272 and vinorelbine
10/30/2013EP2655706A2 Methods of screening compounds that are cytotoxic to tumor cells and methods of treating tumor cells using such compound
10/30/2013EP2655418A2 Anti-mesothelin antibodies and immunoconjugates
10/30/2013EP2655413A1 Polypeptide-polynucleotide-complex and its use in targeted effector moiety delivery
10/30/2013EP2655409A1 Superagonists and antagonists of interleukin-2
10/30/2013EP2655401A2 Inhibitors of the epidermal growth factor receptor-heat shock protein 90 binding interaction
10/30/2013EP2655392A1 Cyclic nucleotide analogs
10/30/2013EP2655379A1 Derivatives of englerin for the treatment of cancer
10/30/2013EP2655375A1 Pyrimidinone derivatives, preparation thereof and pharmaceutical use thereof
10/30/2013EP2655374A1 N-(1-(substituted-phenyl)ethyl)-9h-purin-6-amines as pi3k inhibitors
10/30/2013EP2655372A2 Pyrroloquinolinyl-pyrrolidine-2,5-dione compositions and methods for preparing and using same
10/30/2013EP2655359A1 Conjugated 3-(indolyl)- and 3-(azaindolyl)-4-arylmaleimide compounds and their use in tumor treatment
1 ... 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 ... 2211